Gene: LRRC41
Official Full Name: leucine rich repeat containing 41provided by HGNC
Gene Summary: Predicted to enable identical protein binding activity. Predicted to be involved in protein ubiquitination. Located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02837 | LRRC41 Knockout cell line (HeLa) | Human | LRRC41 | 1:3~1:6 | Negative | Online Inquiry |
KO02838 | LRRC41 Knockout cell line (HCT 116) | Human | LRRC41 | 1:2~1:4 | Negative | Online Inquiry |
KO02839 | LRRC41 Knockout cell line (HEK293) | Human | LRRC41 | 1:3~1:6 | Negative | Online Inquiry |
KO02840 | LRRC41 Knockout cell line (A549) | Human | LRRC41 | 1:3~1:4 | Negative | Online Inquiry |
LRRC41 Gene Knockout Cell Lines represent a valuable breakthrough in cellular biology, providing a dedicated platform for studying the function of the LRRC41 gene. This gene, which encodes a leucine-rich repeat protein believed to play a role in various cellular processes such as protein-protein interactions and signaling pathways, has been implicated in several diseases. By utilizing CRISPR-Cas9 technology, these knockout cell lines have been engineered to eliminate the expression of LRRC41, allowing researchers to investigate the gene's contributions to cellular behavior in a controlled environment.
The key function of LRRC41 Gene Knockout Cell Lines lies in their ability to facilitate functional assays that elucidate the biological pathways involving LRRC41. Researchers can analyze changes in cell proliferation, differentiation, and response to external stimuli, providing insights into the gene’s role in disease pathogenesis. This targeted approach enables the identification of potential therapeutic targets, fostering the development of novel treatments.
Scientifically, these cell lines are crucial in both basic research and translational applications. They enable the examination of gene function in the context of specific diseases, including cancer, neurodegenerative disorders, and autoimmune conditions. The ability to conduct comprehensive phenotypic profiling in these knockout lines makes them indispensable tools in academic and pharmaceutical research settings.
One of the unique advantages of using LRRC41 Gene Knockout Cell Lines is that they are rigorously validated for specificity and reproducibility, ensuring that researchers receive reliable and consistent data. This sets them apart from other models, which may rely on non-specific gene silencing techniques. Additionally, by providing detailed characterization data, our product empowers users to make informed decisions in their experimental designs.
Researchers and clinicians will find great value in our LRRC41 Gene Knockout Cell Lines as they streamline the process of identifying gene function and its implications in disease, ultimately accelerating translational research efforts. Our commitment to excellence in biological product development, combined with our expertise in gene editing technologies, positions us as a leader in providing high-quality, relevant cellular models that meet the needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.